ZEGALOGUE is a rescue treatment that helps people with diabetes recover from very low blood sugar (severe hypoglycemia) when they need help from others.
In clinical trials, median time to blood sugar recovery was 10 minutes in adults, adolescents, and children aged 6 years and older.
ZEGALOGUE® was studied in a clinical trial program of people with type 1 diabetes. Two trials were conducted in adults, and a third trial was conducted in children and adolescents aged 6 to 17 years. In all 3 trials, the results of participants who received ZEGALOGUE were compared with the results of those who received placebo following insulin-induced low blood sugar. The primary goal in all 3 trials was to measure the time to blood sugar recovery, defined as an increase in blood sugar of at least 20 mg/dL from the time of administration, without additional intervention.
In clinical trials, blood sugar levels recovered with a single dose.
ZEGALOGUE® was studied in a clinical trial program of people with type 1 diabetes. Two trials were conducted in adults, and a third trial was conducted in children and adolescents aged 6 to 17 years. In all 3 trials, the results of participants who received ZEGALOGUE were compared with the results of those who received placebo following insulin-induced low blood sugar. The primary goal in all 3 trials was to measure the time to blood sugar recovery, defined as an increase in blood sugar of at least 20 mg/dL from the time of administration, without additional intervention.
Available in an autoinjector or
a prefilled syringe.